This site uses cookies, including third-party cookies, that help us to provide and improve our services. Read More

Liver Cancer Diagnostics Market

Liver Cancer Diagnostics Market

Liver Cancer Diagnostics Market Size, Share & Trends Analysis by Test Type (AFP Tests for Liver Cancer Diagnostics, LFTs for Liver Cancer Diagnostics, Biopsy for Liver Cancer Diagnostics), By End-User (Hospital-associated Labs, Independent Diagnostic Laboratories) & Regional Forecast, 2021-2031

Liver Cancer Diagnostics Market
FACT73MR
  • Oct-2021
  • List of Tables : 165
  • List of Figures : 51
  • 170 Pages
  • Healthcare

Table of Content

1. Global Liver Cancer Diagnostics Market - Executive Summary

2. Global Liver Cancer Diagnostics Market Overview

2.1. Introduction

       2.1.1. Global Liver Cancer Diagnostics Market Taxonomy

       2.1.2. Global Liver Cancer Diagnostics Market Definition

2.2. Global Liver Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2016-2031

       2.2.1. Global Liver Cancer Diagnostics Market Y-o-Y Growth

2.3. Global Liver Cancer Diagnostics Market Dynamics

       2.3.1. Drivers

       2.3.2. Restraints

       2.3.3. Trends

2.4. Supply Chain

2.5. Epidemiology

2.6. List of Distributors

2.7. Average Pricing Analysis 

2.8. Regulations

2.9. Key Participants Market Presence (Intensity Map) By Region

3. Global Liver Cancer Diagnostics Market Analysis and Forecast By Test Type 

3.1. Global Liver Cancer Diagnostics Market Size and Forecast By Test Type, 2016-2031

       3.1.1. AFP Tests Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

                3.1.1.1. Revenue (US$ Mn) Comparison, By Region

                3.1.1.2. Market Share Comparison, By Region

                3.1.1.3. Y-o-Y growth Comparison, By Region

       3.1.2. LFTs Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

                3.1.2.1. Revenue (US$ Mn) Comparison, By Region

                3.1.2.2. Market Share Comparison, By Region

                3.1.2.3. Y-o-Y growth Comparison, By Region

       3.1.3. Biopsy Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

                3.1.3.1. Revenue (US$ Mn) Comparison, By Region

                3.1.3.2. Market Share Comparison, By Region

                3.1.3.3. Y-o-Y growth Comparison, By Region

       3.1.4. Other  Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

                3.1.4.1. Revenue (US$ Mn) Comparison, By Region

                3.1.4.2. Market Share Comparison, By Region

                3.1.4.3. Y-o-Y growth Comparison, By Region

4. Global Liver Cancer Diagnostics Market Analysis and Forecast By End User 

4.1. Global Liver Cancer Diagnostics Market Size and Forecast By End User, 2016-2031

       4.1.1. Hospital Associated Labs Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

                4.1.1.1. Revenue (US$ Mn) Comparison, By Region

                4.1.1.2. Market Share Comparison, By Region

                4.1.1.3. Y-o-Y growth Comparison, By Region

       4.1.2. Independent Diagnostic Laboratories Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

                4.1.2.1. Revenue (US$ Mn) Comparison, By Region

                4.1.2.2. Market Share Comparison, By Region

                4.1.2.3. Y-o-Y growth Comparison, By Region

       4.1.3. Cancer Research Institutes Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

                4.1.3.1. Revenue (US$ Mn) Comparison, By Region

                4.1.3.2. Market Share Comparison, By Region

                4.1.3.3. Y-o-Y growth Comparison, By Region

       4.1.4. Others Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

                4.1.4.1. Revenue (US$ Mn) Comparison, By Region

                4.1.4.2. Market Share Comparison, By Region

                4.1.4.3. Y-o-Y growth Comparison, By Region

5. Global Liver Cancer Diagnostics Market Analysis and Forecast By Region

5.1. Global Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       5.1.1. North America Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

                5.1.1.1. Revenue (US$ Mn) Comparison, By Test Type 

                5.1.1.2. Revenue (US$ Mn) Comparison, By End User 

       5.1.2. Latin America Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

                5.1.2.1. Revenue (US$ Mn) Comparison, By Test Type 

                5.1.2.2. Revenue (US$ Mn) Comparison, By End User 

       5.1.3. Europe Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

                5.1.3.1. Revenue (US$ Mn) Comparison, By Test Type 

                5.1.3.2. Revenue (US$ Mn) Comparison, By End User 

       5.1.4. Japan Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

                5.1.4.1. Revenue (US$ Mn) Comparison, By Test Type 

                5.1.4.2. Revenue (US$ Mn) Comparison, By End User 

       5.1.5. APEJ Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

                5.1.5.1. Revenue (US$ Mn) Comparison, By Test Type 

                5.1.5.2. Revenue (US$ Mn) Comparison, By End User 

       5.1.6. MEA Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

                5.1.6.1. Revenue (US$ Mn) Comparison, By Test Type 

                5.1.6.2. Revenue (US$ Mn) Comparison, By End User 

6. North America Liver Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031

6.1. US Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       6.1.1. Revenue (US$ Mn) Comparison, By Test Type 

       6.1.2. Revenue (US$ Mn) Comparison, By End User 

6.2. Canada Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       6.2.1. Revenue (US$ Mn) Comparison, By Test Type 

       6.2.2. Revenue (US$ Mn) Comparison, By End User 

7. Latin America Liver Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031

7.1. Brazil Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       7.1.1. Revenue (US$ Mn) Comparison, By Test Type 

       7.1.2. Revenue (US$ Mn) Comparison, By End User 

7.2. Mexico Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       7.2.1. Revenue (US$ Mn) Comparison, By Test Type 

       7.2.2. Revenue (US$ Mn) Comparison, By End User 

7.3. Argentina Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       7.3.1. Revenue (US$ Mn) Comparison, By Test Type 

       7.3.2. Revenue (US$ Mn) Comparison, By End User 

8. Europe Liver Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031

8.1. Germany Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       8.1.1. Revenue (US$ Mn) Comparison, By Test Type 

       8.1.2. Revenue (US$ Mn) Comparison, By End User 

8.2. UK Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       8.2.1. Revenue (US$ Mn) Comparison, By Test Type 

       8.2.2. Revenue (US$ Mn) Comparison, By End User 

8.3. France Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       8.3.1. Revenue (US$ Mn) Comparison, By Test Type 

       8.3.2. Revenue (US$ Mn) Comparison, By End User 

8.4. Spain Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       8.4.1. Revenue (US$ Mn) Comparison, By Test Type 

       8.4.2. Revenue (US$ Mn) Comparison, By End User 

8.5. Italy Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       8.5.1. Revenue (US$ Mn) Comparison, By Test Type 

       8.5.2. Revenue (US$ Mn) Comparison, By End User 

8.6. Nordic Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       8.6.1. Revenue (US$ Mn) Comparison, By Test Type 

       8.6.2. Revenue (US$ Mn) Comparison, By End User 

9. Japan Liver Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031

9.1. Japan  Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       9.1.1. Revenue (US$ Mn) Comparison, By Test Type 

       9.1.2. Revenue (US$ Mn) Comparison, By End User 

10. APEJ Liver Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031

10.1. China Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       10.1.1. Revenue (US$ Mn) Comparison, By Test Type 

       10.1.2. Revenue (US$ Mn) Comparison, By End User 

10.2. India Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       10.2.1. Revenue (US$ Mn) Comparison, By Test Type 

       10.2.2. Revenue (US$ Mn) Comparison, By End User 

10.3. Malaysia Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       10.3.1. Revenue (US$ Mn) Comparison, By Test Type 

       10.3.2. Revenue (US$ Mn) Comparison, By End User 

10.4. Thailand Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       10.4.1. Revenue (US$ Mn) Comparison, By Test Type 

       10.4.2. Revenue (US$ Mn) Comparison, By End User 

10.5. Singapore Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       10.5.1. Revenue (US$ Mn) Comparison, By Test Type 

       10.5.2. Revenue (US$ Mn) Comparison, By End User 

10.6. Australia Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       10.6.1. Revenue (US$ Mn) Comparison, By Test Type 

       10.6.2. Revenue (US$ Mn) Comparison, By End User 

11. MEA Liver Cancer Diagnostics Market Analysis and Forecast, By Country, 2016-2031

11.1. GCC Countries Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       11.1.1. Revenue (US$ Mn) Comparison, By Test Type 

       11.1.2. Revenue (US$ Mn) Comparison, By End User 

11.2. South Africa Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       11.2.1. Revenue (US$ Mn) Comparison, By Test Type 

       11.2.2. Revenue (US$ Mn) Comparison, By End User 

11.3. Nigeria Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       11.3.1. Revenue (US$ Mn) Comparison, By Test Type 

       11.3.2. Revenue (US$ Mn) Comparison, By End User 

11.4. Israel Liver Cancer Diagnostics Market Size and Forecast, 2016-2031

       11.4.1. Revenue (US$ Mn) Comparison, By Test Type 

       11.4.2. Revenue (US$ Mn) Comparison, By End User 

12. Global Liver Cancer Diagnostics Market Company/Manufactures/Distributors/Suppliers Profile and Revenue Projections

12.1. Company Share Analysis By Region

12.2. Abbott Laboratories

       12.2.1. Company Overview

       12.2.2. Liver Cancer Diagnostics Market Test Type list

       12.2.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials

       12.2.4. Key Developments

       12.2.5. SWOT Analysis

12.3. Agilent Technologies, Inc.

       12.3.1. Company Overview

       12.3.2. Liver Cancer Diagnostics Market Test Type list

       12.3.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials

       12.3.4. Key Developments

       12.3.5. SWOT Analysis

12.4. Bio Rad Laboratories Inc.

       12.4.1. Company Overview

       12.4.2. Liver Cancer Diagnostics Market Test Type list

       12.4.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials

       12.4.4. Key Developments

       12.4.5. SWOT Analysis

12.5. F. Hoffmann-La Roche Ltd.

       12.5.1. Company Overview

       12.5.2. Liver Cancer Diagnostics Market Test Type list

       12.5.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials

       12.5.4. Key Developments

       12.5.5. SWOT Analysis

12.6. Thermo Fisher Scientific Inc.

       12.6.1. Company Overview

       12.6.2. Liver Cancer Diagnostics Market Test Type list

       12.6.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials

       12.6.4. Key Developments

       12.6.5. SWOT Analysis

12.7. Magna International Inc. 

       12.7.1. Company Overview

       12.7.2. Liver Cancer Diagnostics Market Test Type list

       12.7.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials

       12.7.4. Key Developments

       12.7.5. SWOT Analysis

12.8. Hyundai Mobis 

       12.8.1. Company Overview

       12.8.2. Liver Cancer Diagnostics Market Test Type list

       12.8.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials

       12.8.4. Key Developments

       12.8.5. SWOT Analysis

12.9. Plastic Omnium Group 

       12.9.1. Company Overview

       12.9.2. Liver Cancer Diagnostics Market Test Type list

       12.9.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials

       12.9.4. Key Developments

       12.9.5. SWOT Analysis

12.10. Samvardhana Motherson Automotive Systems Group 

       12.10.1. Company Overview

       12.10.2. Liver Cancer Diagnostics Market Test Type list

       12.10.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials

       12.10.4. Key Developments

       12.10.5. SWOT Analysis

12.11. SL Corporation 

       12.11.1. Company Overview

       12.11.2. Liver Cancer Diagnostics Market Test Type list

       12.11.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials

       12.11.4. Key Developments

       12.11.5. SWOT Analysis

12.12. Valeo S.A. 

       12.12.1. Company Overview

       12.12.2. Liver Cancer Diagnostics Market Test Type list

       12.12.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials

       12.12.4. Key Developments

       12.12.5. SWOT Analysis

12.13. Montaplast GmbH

       12.13.1. Company Overview

       12.13.2. Liver Cancer Diagnostics Market Test Type list

       12.13.3. Liver Cancer Diagnostics Market Test Type Sales Data and Key Financials

       12.13.4. Key Developments

       12.13.5. SWOT Analysis

13. Research Methodology

14. Secondary and Primary Sources

15. Assumptions and Acronyms

16. Disclaimer

Know More Details About the Report

List of Tables

TABLE 1 Global Liver Cancer Diagnostics Market Value (US$ Mn), 2016-2020

TABLE 2 Global Liver Cancer Diagnostics Market Value (US$ Mn), 2021-2031

TABLE 3 Global Liver Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2015-2031

TABLE 4 Global AFP Tests Segment Value (US$ Mn), By Region 2016-2020

TABLE 5 Global AFP Tests Segment Value (US$ Mn), By Region 2021-2031

TABLE 6 Global AFP Tests Segment Market Share, By Region 2016-2020

TABLE 7 Global AFP Tests Segment Market Share, By Region 2021-2031

TABLE 8 Global AFP Tests Segment Y-o-Y, By Region 2015-2031

TABLE 9 Global LFTs Segment Value (US$ Mn), By Region 2016-2020

TABLE 10 Global LFTs Segment Value (US$ Mn), By Region 2021-2031

TABLE 11 Global LFTs Segment Market Share, By Region 2016-2020

TABLE 12 Global LFTs Segment Market Share, By Region 2021-2031

TABLE 13 Global LFTs Segment Y-o-Y, By Region 2015-2031

TABLE 14 Global Biopsy Segment Value (US$ Mn), By Region 2016-2020

TABLE 15 Global Biopsy Segment Value (US$ Mn), By Region 2021-2031

TABLE 16 Global Biopsy Segment Market Share, By Region 2016-2020

TABLE 17 Global Biopsy Segment Market Share, By Region 2021-2031

TABLE 18 Global Biopsy Segment Y-o-Y, By Region 2015-2031

TABLE 19 Global Other  Segment Value (US$ Mn), By Region 2016-2020

TABLE 20 Global Other  Segment Value (US$ Mn), By Region 2021-2031

TABLE 21 Global Other  Segment Market Share, By Region 2016-2020

TABLE 22 Global Other  Segment Market Share, By Region 2021-2031

TABLE 23 Global Other  Segment Y-o-Y, By Region 2015-2031

TABLE 24 Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2016-2020

TABLE 25 Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2021-2031

TABLE 26 Global Hospital Associated Labs Segment Market Share, By Region 2016-2020

TABLE 27 Global Hospital Associated Labs Segment Market Share, By Region 2021-2031

TABLE 28 Global Hospital Associated Labs Segment Y-o-Y, By Region 2015-2031

TABLE 29 Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2016-2020

TABLE 30 Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2021-2031

TABLE 31 Global Independent Diagnostic Laboratories Segment Market Share, By Region 2016-2020

TABLE 32 Global Independent Diagnostic Laboratories Segment Market Share, By Region 2021-2031

TABLE 33 Global Independent Diagnostic Laboratories Segment Y-o-Y, By Region 2015-2031

TABLE 34 Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2016-2020

TABLE 35 Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2021-2031

TABLE 36 Global Cancer Research Institutes Segment Market Share, By Region 2016-2020

TABLE 37 Global Cancer Research Institutes Segment Market Share, By Region 2021-2031

TABLE 38 Global Cancer Research Institutes Segment Y-o-Y, By Region 2015-2031

TABLE 39 Global Others Segment Value (US$ Mn), By Region 2016-2020

TABLE 40 Global Others Segment Value (US$ Mn), By Region 2021-2031

TABLE 41 Global Others Segment Market Share, By Region 2016-2020

TABLE 42 Global Others Segment Market Share, By Region 2021-2031

TABLE 43 Global Others Segment Y-o-Y, By Region 2015-2031

TABLE 44 North America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 45 North America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 46 North America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 47 North America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 48 Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 49 Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 50 Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 51 Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 52 Europe Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 53 Europe Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 54 Europe Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 55 Europe Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 56 Japan Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 57 Japan Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 58 Japan Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 59 Japan Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 60 APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 61 APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 62 APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 63 APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 64 MEA Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 65 MEA Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 66 MEA Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 67 MEA Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 68 US Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 69 US Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 70 US Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 71 US Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 72 Canada Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 73 Canada Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 74 Canada Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 75 Canada Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 76 Brazil Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 77 Brazil Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 78 Brazil Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 79 Brazil Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 80 Mexico Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 81 Mexico Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 82 Mexico Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 83 Mexico Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 84 Argentina Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 85 Argentina Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 86 Argentina Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 87 Argentina Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 88 Germany Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 89 Germany Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 90 Germany Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 91 Germany Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 92 UK Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 93 UK Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 94 UK Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 95 UK Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 96 France Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 97 France Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 98 France Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 99 France Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 100 Spain Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 101 Spain Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 102 Spain Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 103 Spain Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 104 Italy Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 105 Italy Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 106 Italy Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 107 Italy Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 108 Nordic Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 109 Nordic Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 110 Nordic Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 111 Nordic Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 112 Japan  Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 113 Japan  Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 114 Japan  Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 115 Japan  Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 116 China Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 117 China Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 118 China Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 119 China Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 120 India Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 121 India Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 122 India Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 123 India Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 124 Malaysia Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 125 Malaysia Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 126 Malaysia Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 127 Malaysia Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 128 Thailand Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 129 Thailand Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 130 Thailand Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 131 Thailand Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 132 Singapore Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 133 Singapore Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 134 Singapore Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 135 Singapore Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 136 Australia Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 137 Australia Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 138 Australia Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 139 Australia Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 140 GCC Countries Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 141 GCC Countries Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 142 GCC Countries Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 143 GCC Countries Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 144 South Africa Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 145 South Africa Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 146 South Africa Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 147 South Africa Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 148 Nigeria Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 149 Nigeria Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 150 Nigeria Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 151 Nigeria Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 152 Israel Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

TABLE 153 Israel Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

TABLE 154 Israel Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

TABLE 155 Israel Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

TABLE 156 Abbott Laboratories Value (US$ Mn), By Test Type 2021-2031

TABLE 157 Abbott Laboratories Value (US$ Mn), By End User 2021-2031

TABLE 158 Agilent Technologies, Inc. Value (US$ Mn), By Test Type 2021-2031

TABLE 159 Agilent Technologies, Inc. Value (US$ Mn), By End User 2021-2031

TABLE 160 Bio Rad Laboratories Inc. Value (US$ Mn), By Test Type 2021-2031

TABLE 161 Bio Rad Laboratories Inc. Value (US$ Mn), By End User 2021-2031

TABLE 162 F. Hoffmann-La Roche Ltd. Value (US$ Mn), By Test Type 2021-2031

TABLE 163 F. Hoffmann-La Roche Ltd. Value (US$ Mn), By End User 2021-2031

TABLE 164 Thermo Fisher Scientific Inc. Value (US$ Mn), By Test Type 2021-2031

TABLE 165 Thermo Fisher Scientific Inc. Value (US$ Mn), By End User 2021-2031

Have a report related query? Speak to us directly

List of Figures

FIG. 1 Global Liver Cancer Diagnostics Market Value (US$ Mn), 2016-2020

FIG. 2 Global Liver Cancer Diagnostics Market Value (US$ Mn) Forecast, 2021-2031

FIG. 3 Global Liver Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2015-2031

FIG. 4 Global AFP Tests Segment Market Value (US$ Mn) By Region, 2016-2020

FIG. 5 Global AFP Tests Segment Market Value (US$ Mn) By Region, 2021-2031

FIG. 6 Global AFP Tests Segment Y-o-Y Growth Rate, By Region, 2015-2031

FIG. 7 Global LFTs Segment Market Value (US$ Mn) By Region, 2016-2020

FIG. 8 Global LFTs Segment Market Value (US$ Mn) By Region, 2021-2031

FIG. 9 Global LFTs Segment Y-o-Y Growth Rate, By Region, 2015-2031

FIG. 10 Global Biopsy Segment Market Value (US$ Mn) By Region, 2016-2020

FIG. 11 Global Biopsy Segment Market Value (US$ Mn) By Region, 2021-2031

FIG. 12 Global Biopsy Segment Y-o-Y Growth Rate, By Region, 2015-2031

FIG. 13 Global Other  Segment Market Value (US$ Mn) By Region, 2016-2020

FIG. 14 Global Other  Segment Market Value (US$ Mn) By Region, 2021-2031

FIG. 15 Global Other  Segment Y-o-Y Growth Rate, By Region, 2015-2031

FIG. 16 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2016-2020

FIG. 17 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2021-2031

FIG. 18 Global Hospital Associated Labs Segment Y-o-Y Growth Rate, By Region, 2015-2031

FIG. 19 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2016-2020

FIG. 20 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2021-2031

FIG. 21 Global Independent Diagnostic Laboratories Segment Y-o-Y Growth Rate, By Region, 2015-2031

FIG. 22 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2016-2020

FIG. 23 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2021-2031

FIG. 24 Global Cancer Research Institutes Segment Y-o-Y Growth Rate, By Region, 2015-2031

FIG. 25 Global Others Segment Market Value (US$ Mn) By Region, 2016-2020

FIG. 26 Global Others Segment Market Value (US$ Mn) By Region, 2021-2031

FIG. 27 Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2031

FIG. 28 North America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

FIG. 29 North America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

FIG. 30 North America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

FIG. 31 North America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

FIG. 32 Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

FIG. 33 Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

FIG. 34 Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

FIG. 35 Latin America Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

FIG. 36 Europe Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

FIG. 37 Europe Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

FIG. 38 Europe Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

FIG. 39 Europe Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

FIG. 40 Japan Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

FIG. 41 Japan Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

FIG. 42 Japan Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

FIG. 43 Japan Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

FIG. 44 APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

FIG. 45 APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

FIG. 46 APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

FIG. 47 APEJ Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

FIG. 48 MEA Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2016-2020

FIG. 49 MEA Liver Cancer Diagnostics Market Value (US$ Mn), By Test Type 2021-2031

FIG. 50 MEA Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2016-2020

FIG. 51 MEA Liver Cancer Diagnostics Market Value (US$ Mn), By End User 2021-2031

Liver Cancer Diagnostics Market- Scope of Report

A recent study by Fact.MR on the liver cancer diagnostics market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with the development of liver cancer diagnostics.

The study also provides the dynamics that are responsible for influencing the future status of the market over the forecast period. A detailed assessment of value chain analysis, business execution, cost structure analysis, and supply chain analysis across regional markets has been covered in the report.

A list of prominent players manufacturing liver cancer diagnostic products, along with their product portfolios, key strategies, and SWOT analysis, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including revenue growth, product enhancements, and revenue generation from liver cancer diagnostics across the globe.

A comprehensive estimate on the market has been provided through an optimistic scenario as well as a conservative scenario, taking into account revenue through liver cancer diagnostics during the forecast period.

Analysis on Market Size Evaluation

The market has been analyzed for each market segment in terms of volume (units), and value (US$ Mn).

Market estimates at global and regional levels for liver cancer diagnostics are available in terms of “US$ Mn”. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a company can look to achieve, along with identifying potential resources, considering the revenue perspective in the global liver cancer diagnostics market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include market forces analysis, which is expected to have a momentous influence on the growth of the liver cancer diagnostics market during the forecast period.

Country-specific valuation on revenue for liver cancer diagnostics has been offered for each regional market, along with market scope estimates and forecasts, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value for key countries has also been included in the report.

In-depth Analysis on Competition

The report sheds light on leading providers of liver cancer diagnostics, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the liver cancer diagnostics has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the liver cancer diagnostics market.

- FAQs -

North America is anticipated to dominate the global industry in terms of revenue with 35% market share.

Illumina Inc., Foundation Medicine Inc., Danaher Corporation Sysmex Corporation, and Biocept Inc. are key players profiled in this survey.

Hospital-associated labs are expected to account for majority of revenue share.

Rising prevalence of obesity & diabetes and increasing consumption of tobacco & alcohol are surging cancer cases, and thereby demand for liver cancer diagnostics.

Liver cancer diagnostics market growth through 2031 is anticipated to be at a CAGR of 8.2%.

Sales revenue from liver cancer diagnostics totaled nearly US$ 10 Bn in 2020.

Demand for MRI imaging tests for liver cancer diagnostics and CT scans is prominent in this marketplace.

By 2031, the global market for liver cancer diagnostics is estimated to be worth around US$ 22 Bn.

Need an Exclusive Report for your Unique Requirement?

- Related Reports -

Chick Embryo Cell Rabies Vaccine Market

Chick Embryo Cell Rabies Vaccine Market research report covers detailed information on Global Chick ...

Meniscus Repair Systems Market

Meniscus Repair Systems Market research report covers detailed information on Global Meniscus Repair...

Oncology Small Molecule Drugs Market

Oncology Small Molecule Drugs Market is expected to reach a valuation of US$ 120 billion by 2031. Or...

Genetic Testing Services Market

The global genetic testing services market is expected to be leveraged considerably in the future. P...

- Our Clients -

Report Client

- Evaluate How Fact.MR's Report Can Help. -

Is the market research conducted by Fact.MR?

Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.

What research methodology is followed by Fact.MR?

Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.

What are the sources of secondary research?

Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.

Who are the respondents for primary research?

Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.

Is a sample of this report available for evaluation?

Yes, you can request a sample, and it will be sent to you through an email.